Bayer AG (BAYN) PT Set at €118.00 by equinet AG
Bayer AG (FRA:BAYN) has been assigned a €118.00 ($129.67) target price by analysts at equinet AG in a research note issued on Tuesday. The firm currently has a a “buy” rating on the stock.
A number of other analysts have also recently commented on the company. Deutsche Bank AG set a €124.00 ($136.26) price target on Bayer AG and gave the stock a “buy” rating in a research report on Monday, July 11th. Commerzbank AG set a €102.00 ($112.09) price target on Bayer AG and gave the stock a “buy” rating in a research report on Tuesday, August 30th. Goldman Sachs Group Inc. reaffirmed a “buy” rating on shares of Bayer AG in a research report on Thursday, July 28th. DZ Bank AG reaffirmed a “neutral” rating on shares of Bayer AG in a research report on Monday, August 8th. Finally, S&P Global Inc. set a €120.00 ($131.87) price target on Bayer AG and gave the stock a “buy” rating in a research report on Tuesday, September 6th. Two equities research analysts have rated the stock with a sell rating, ten have given a hold rating and thirteen have assigned a buy rating to the company. The stock has an average rating of “Hold” and an average target price of €112.29 ($123.40).
Shares of Bayer AG (FRA:BAYN) opened at 90.415 on Tuesday. The firm has a 50-day moving average price of €92.02 and a 200-day moving average price of €94.48. Bayer AG has a 12 month low of €83.87 and a 12 month high of €127.21. The stock has a market cap of €74.77 billion and a PE ratio of 16.605.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at https://www.americanbankingnews.com/2016/10/18/bayer-ag-bayn-pt-set-at-118-00-by-equinet-ag.html
About Bayer AG
Receive News & Ratings for Bayer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer AG and related companies with MarketBeat.com's FREE daily email newsletter.